Alzheimer’s initiative aims to enhance clinical care … FDA proposes rule allowing drugs to be imported from Canada … New Parkinson’s drug meets safety criteria in mid-stage trial … Medicinal...
Clinical Briefs for Monday, November 25
By
Alicia Lasek
Nov 22, 2019
High exposure to common antibiotics linked to Parkinson’s … Women, seniors have higher hypertension-associated atrial fibrillation risk … COPD death rates among North American women haven’t budged
Clinical Briefs for Friday, November 15
By
Alicia Lasek
Nov 14, 2019
Earlier onset, cognitive impairment raise mortality odds in Parkinson’s disease … Mortality risk competes with benefits of oral anticoagulants for A-Fib … Pacemakers improve heart function in chemotherapy-induced...
Machine learning tracks tremor severity over time in Parkinson’s
By
Alicia Lasek
Oct 30, 2019
Wearable devices that use machine learning can accurately detect and rate Parkinson’s disease tremors outside the clinical setting.
Polypharmacy is linked to cognitive decline in Parkinson’s
By
Alicia Lasek
Oct 20, 2019
People with newly diagnosed Parkinson’s who are taking multiple medications are at higher risk of cognitive decline, say Japanese researchers.
Clinical Briefs for Friday, October 18
By
Alicia Lasek
Oct 17, 2019
New strategy for Parkinson’s treatment tested … Metabolic dysfunction a primary cause of Alzheimer’s disease … Benefits of statins ‘marginal’ for most healthy people … Study reveals insight...
Clinical Briefs for Thursday, October 17
By
Alicia Lasek
Oct 16, 2019
Music enhances movement control in Parkinson’s … New clinical overview: Preventing and managing frailty … U.S. Senate hears expert testimony on falls prevention
Large-scale study to test cannabinoid use in Parkinson’s-related psychosis
By
Alicia Lasek
Oct 14, 2019
A large-scale British trial is set to test whether cannabinoids can effectively treat hallucinations and delusions in Parkinson’s disease.
Parkinson’s symptoms can be monitored effectively in the home: study
By
Alicia Lasek
Oct 07, 2019
Parkinson’s disease symptoms can be monitored electronically while people go about their daily activities, according to a new proof-of-concept study.
Clinical Briefs for Tuesday, October 8
By
Alicia Lasek
Oct 07, 2019
Skin test designed to detect early Parkinson’s … Oral anticoagulant slows Alzheimer’s progression in mice … Oral capsule delivers injection-only drugs such as insulin